iShares Neuroscience and Healthcare ETF Rating → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free IBRN Stock Alerts $23.78 -0.48 (-1.98%) (As of 05/8/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHoldingsOwnershipRatingsStock AnalysisChartHoldingsOwnershipRatings iShares Neuroscience and Healthcare ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBRN Aggregate RatingModerate Buy2.71Holdings in IBRN have an aggregate rating of Moderate Buy based on 328 analyst ratings issued in the past year covering 42 companies (86.7% of the portfolio).IBRN Aggregate Price Target$39.5966.47% UpsideHigh Prediction$51.50Average Prediction$39.59Low Prediction$29.32Holdings in IBRN have an aggregate price target of $39.59 and a range of $29.32 to $51.50 covering 42 companies (86.7% of the portfolio).IBRN Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy24 Buy rating(s)Moderate Buy13 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Neuroscience and Healthcare ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 42 IBRN Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.93%NBIXNeurocrine Biosciences$139.45+0.3%5 of 5 stars2.74$147.88 6.0%23Analyst Revision4.79%SRPTSarepta Therapeutics$131.80-0.6%4 of 5 stars2.79$160.60 21.9%14Insider SellingAnalyst Revision4.66%CERECerevel Therapeutics$42.25+0.5%0 of 5 stars2.11$42.67 1.0%9Positive News4.59%ARGXargenx$383.56-0.7%3 of 5 stars2.71$528.16 37.7%21News Coverage4.51%ITCIIntra-Cellular Therapies$65.79-1.8%5 of 5 stars2.90$90.17 37.1%10Earnings ReportAnalyst ForecastAnalyst Revision4.50%AXNXAxonics$67.41+0.1%3 of 5 stars2.38$70.73 4.9%13Analyst Forecast4.50%PTCTPTC Therapeutics$31.19+0.2%2 of 5 stars1.92$33.67 7.9%13Positive News4.48%BIIBBiogen$222.04+1.1%5 of 5 stars2.65$290.92 31.0%264.20%XENEXenon Pharmaceuticals$42.56-0.9%2 of 5 stars3.00$59.44 39.7%9News Coverage3.79%BHVNBiohaven$41.44+1.6%3 of 5 stars3.00$52.13 25.8%8Upcoming Earnings3.68%ALKSAlkermes$24.30+0.8%5 of 5 stars2.50$35.38 45.6%10Analyst Revision3.25%ACADACADIA Pharmaceuticals$15.28-10.8%4 of 5 stars2.80$31.75 107.8%15Earnings ReportAnalyst ForecastNews CoverageGap UpHigh Trading Volume3.23%SUPNSupernus Pharmaceuticals$29.85-4.6%4 of 5 stars3.00$41.00 37.4%1News CoverageHigh Trading Volume3.15%IARTIntegra LifeSciences$25.23+1.3%5 of 5 stars2.00$36.80 45.9%11Earnings ReportAnalyst DowngradeNews Coverage3.04%AVDLAvadel Pharmaceuticals$15.90-2.2%2 of 5 stars3.00$23.67 48.8%6Earnings ReportAnalyst ForecastNews Coverage3.00%CPRXCatalyst Pharmaceuticals$15.66+6.4%5 of 5 stars3.00$26.43 68.8%5News Coverage2.53%EWTXEdgewise Therapeutics$20.40-2.3%1 of 5 stars3.00$31.20 52.9%5Gap Down2.17%PRTAProthena$21.95-4.7%3 of 5 stars2.71$68.14 210.4%7Earnings ReportAnalyst ForecastNews CoverageGap Down2.02%DYNDyne Therapeutics$26.33+2.5%3 of 5 stars3.13$37.75 43.4%8Analyst ForecastAnalyst RevisionNews Coverage1.70%SAVACassava Sciences$21.04-2.5%3 of 5 stars3.00$124.00 489.4%1Upcoming Earnings1.58%SRRKScholar Rock$14.57+0.5%5 of 5 stars3.17$25.17 72.7%6Earnings ReportAnalyst ForecastNews Coverage1.41%LBPHLongboard Pharmaceuticals$21.96+1.2%3 of 5 stars3.00$43.67 98.8%6Analyst Forecast0.98%WVEWave Life Sciences$5.84-0.2%5 of 5 stars2.71$10.14 73.7%7News CoverageGap Down0.91%NMRANeumora Therapeutics$9.88+4.9%1 of 5 stars2.86$22.57 128.5%7Earnings Report0.80%NVRONevro$10.49+3.2%2 of 5 stars2.00$20.00 90.7%13Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage0.74%VYGRVoyager Therapeutics$8.39-2.1%4 of 5 stars2.86$19.33 130.4%7Upcoming Earnings0.74%ALECAlector$5.193 of 5 stars2.57$14.86 186.3%7Analyst ForecastNews Coverage0.68%PEPGPepGen$13.85+1.1%3 of 5 stars3.00$24.67 78.1%20.66%DNTHDianthus Therapeutics$24.66+3.6%1 of 5 stars3.00$42.40 71.9%50.62%SLDBSolid Biosciences$10.34+0.9%3 of 5 stars3.00$18.25 76.5%60.61%AVXLAnavex Life Sciences$3.84+3.5%3 of 5 stars3.00$40.00 941.7%1Upcoming EarningsNews Coverage0.58%ANNXAnnexon$5.18+6.4%3 of 5 stars3.00$14.43 178.5%6Upcoming Earnings0.54%ANROAlto Neuroscience$14.54+4.8%2 of 5 stars3.00$32.33 122.4%5News CoverageNegative News0.50%TRDAEntrada Therapeutics$14.42+2.6%2 of 5 stars3.00$21.00 45.6%2Analyst RevisionNews Coverage0.47%AXGNAxoGen$6.06+3.2%2 of 5 stars3.00$10.67 76.0%3Analyst Downgrade0.44%KYTXKyverna Therapeutics$14.41+13.8%2 of 5 stars3.00$42.75 196.7%5News Coverage0.42%LRMRLarimar Therapeutics$7.85-0.9%2 of 5 stars3.00$18.50 135.7%6News Coverage0.30%CAPRCapricor Therapeutics$5.38+0.2%1 of 5 stars3.00$24.00 346.1%2Upcoming EarningsNews Coverage0.29%NPCENeuroPace$8.15-35.3%3 of 5 stars2.86$15.67 92.2%7Analyst ForecastNews CoverageTrading HaltedHigh Trading Volume0.28%ABOSAcumen Pharmaceuticals$3.55+4.4%3 of 5 stars3.00$12.25 245.1%5Upcoming EarningsNews Coverage0.22%VTGNVistagen Therapeutics$4.51+1.3%1 of 5 stars3.00$19.00 321.3%40.21%ABEOAbeona Therapeutics$4.50+2.3%4 of 5 stars3.00$36.00 700.0%1 This page (NYSEARCA:IBRN) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersThis 1 Biotech Stock has been shocking the marketsHuge Alerts1970’s computer coder Issues Shocking AI WarningInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeThe Crypto 9-5 Escape PlanCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Neuroscience and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
